𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Emerging approaches for the therapy of autoimmune and chronic inflammatory disease

✍ Scribed by Andrew P Cope; Marc Feldmann

Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
138 KB
Volume
16
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Alternative drug delivery approaches for
Alternative drug delivery approaches for the therapy of inflammatory bowel disease
✍ Yvette Meissner; Alf Lamprecht πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 457 KB πŸ‘ 1 views

This article shall give an overview on drug delivery systems for new therapeutic strategies in the treatment of inflammatory bowel disease. The various features of the different approaches allowing locally restricted drug delivery to the inflamed colon are discussed including the main physiological

Inflammatory bowel disease in the settin
Inflammatory bowel disease in the setting of autoimmune pancreatitis
✍ Karthik Ravi; Suresh T. Chari; Santhi S. Vege; William J. Sandborn; Thomas C. Sm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 279 KB πŸ‘ 1 views

Background: Despite scattered case reports, the prevalence of inflammatory bowel disease (IBD) in patients with autoimmune pancreatitis (AIP) is unknown. We sought to better characterize the putative association between the conditions. Methods: Medical records of 71 patients meeting accepted criteri

An Analysis of the Composition of the In
An Analysis of the Composition of the Inflammatory Infiltrate in Autoimmune and Hepatitis B Virus-Induced Chronic Liver Disease
✍ Luis Montano; Fernando Aranguibel; Margarita Boffill; Alison H. Goodall; George πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 524 KB

The composition of the mononuclear cell infiltrate in the liver was studied in patients with autoimmune and hepatitis B virus (HBV)-induced liver disease. The ratio of inducer to cytotoxic/suppressor cells was greater in patients with lupoid chronic active liver disease, primary biliary cirrhosis, a